CRVS
#2332
Corvus Pharmaceuticals, Inc. - Common Stock
14.4 7 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.07%
Monthly Change
+8.31%
6 month change
-17.31%
Year Change
+166.97%
Previous Close
14.7 2
Open
14.6 0
Low
14.3 6
High
14.6 0
Volume
118
Financials
- Market Capitalization 1.22 B
- Employee 37
- Founded 2014
- CEO N/A
- Website www.corvuspharma.com
- Headquarter Delaware, United States
- FIGI BBG009F0TGH8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-14.53
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2301 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.62 USD | -1.28% | -2.40% | +25.60% | +344.38% | 1.29 B USD | ||
| 2322 |  IMTX Immatics N.V. - Ordinary Shares | 9.43 USD | +0.75% | +5.72% | +8.64% | -8.89% | 1.26 B USD | ||
| 2336 |  SANA Sana Biotechnology, Inc. - Common Stock | 4.09 USD | 0.00% | +2.00% | +24.70% | +34.98% | 1.22 B USD | ||
| 2338 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 14.08 USD | -1.68% | -4.61% | -36.66% | +24.60% | 1.20 B USD |
Frequently asked questions about Corvus Pharmaceuticals, Inc.
What is the Corvus Pharmaceuticals, Inc. stock price today?
The current price of Corvus Pharmaceuticals, Inc. (CRVS) is 14.47. Over the past 24 hours, the stock has changed by -0.07%. Follow the CRVS chart for real-time price dynamics.
What is the stock ticker of Corvus Pharmaceuticals, Inc.?
Corvus Pharmaceuticals, Inc. trades under the ticker CRVS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Corvus Pharmaceuticals, Inc. stock going up?
CRVS has changed by -1.70% over the last week, +8.31% over the last month, and +166.97% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Corvus Pharmaceuticals, Inc.?
Corvus Pharmaceuticals, Inc. currently has a market capitalization of 1.22 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Corvus Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Corvus Pharmaceuticals, Inc. reported earnings of -0.19 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Corvus Pharmaceuticals, Inc. net income for the last quarter?
Corvus Pharmaceuticals, Inc. reported net income of -17.96 M for the last quarter. The previous quarter showed -13.69 M, which means net income changed by -31.16%.
How many employees does Corvus Pharmaceuticals, Inc. have?
As of the latest available data, Corvus Pharmaceuticals, Inc. has 37 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Corvus Pharmaceuticals, Inc. stock?
You can buy Corvus Pharmaceuticals, Inc. (CRVS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Corvus Pharmaceuticals, Inc. stock?
Investing in Corvus Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRVS chart and related analysis on metatrader.com as part of your research.